Data Science in Cancer Genomics and Precision Medicine 2.0

Dear Colleagues,

This is a continuation to our series on the hot topic of “Data Science in Cancer Genomics and Precision Medicine”. We have already published a successful Special Issue, receiving interesting contributions and stimulating discussions (https://www.mdpi.com/journal/ijms/special_issues/Genomics_Medicine).

Data science in cancer genomics represents a new interdisciplinary field that applies statistics and next-generation sequencing (NGS) technologies to understand alterations in the genome of cancer cells. The data generated by these technologies are often termed “multi-omics data” and can include information on DNA, RNA, proteins, and epigenetic modifications. The use of data science in cancer genomics allows us to better understand the molecular basis of different cancers and exploit this information to match each patient with the most appropriate molecular targeted therapy, widely known as “precision medicine”. While traditional chemotherapy and radiation treatments target cellular processes that are common to both healthy and cancerous cells, precision medicine specifically directs newly developed treatments to cancer cells based on their underlying molecular profile.

This Special Issue of the International Journal of Molecular Sciences focuses on the research field of cancer genomics and precision medicine and welcomes both original research articles and review papers that deal with the molecular mechanisms underlying modifications in human cancer cells.

Dr. Apostolos Zaravinos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer genomics
• big data
• tumor immunology
• translational oncology
• precision medicine
• next-generation sequencing
• omics
• cancer genomic datasets